Yamamoto Hiroyuki, Horiuchi Shina, Adachi Yasushi, Taniguchi Hiroaki, Nosho Katsuhiko, Min Yongfen, Imai Kohzoh
First Department of Internal Medicine, Sapporo Medical University, South-1, West-16, Chuo-ku, Sapporo 060-8543, Japan.
Carcinogenesis. 2004 Mar;25(3):325-32. doi: 10.1093/carcin/bgh011. Epub 2003 Nov 6.
Expression of E1AF/PEA3 (ETV4), an ets family transcriptional factor, has been implicated in tumor progression through induction of matrix metalloproteinase (MMP) expression. The aim of this study was to examine E1AF mRNA expression and to determine whether it is correlated with progression of, and/or MMP expression in, human gastric cancer. Using the semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), we analyzed 100 gastric cancer tissues for E1AF mRNA expression. Expression of ER81 (ETV1) and ERM (ETV5), the other two members of the PEA3 subfamily, and Ets-1 and Ets-2 was also analyzed. The results were correlated with clinicopathological characteristics and MMP expression. Immunohistochemical analysis and an in vitro invasion assay were also performed. E1AF mRNA expression was detected in 64% of the 100 gastric cancer tissues, but was undetectable or only faintly detected in adjacent non-tumor tissues. E1AF expression was significantly correlated with depth of invasion, lymphatic and venous invasion, lymph node and distant metastasis, advance in pathological tumor-node-metastasis stage and recurrence. Patients with E1AF-positive tumors had significantly shorter overall and disease-free survival periods than did those with E1AF-negative tumors (P < 0.0001 and P < 0.0001, respectively). E1AF expression retained its significant predictive value for overall and disease-free survival in multivariate analysis that included conventional clinicopathological factors (P = 0.0082 and P = 0.0096, respectively). Among the MMPs analyzed, expression of matrilysin (MMP-7) was significantly correlated with E1AF expression. Immunohistochemical expression of E1AF was predominantly observed at the invasive front, where the expression of matrilysin was often co-localized. Antisense E1AF-transfected MKN45 gastric cancer cells expressed reduced levels of matrilysin and were less invasive in vitro than mock-transfected MKN45 cells. The results of this study suggest that E1AF, the expression of which is closely correlated with the expression of matrilysin, plays a key role in the progression of gastric cancer.
E1AF/PEA3(ETV4)是一种ets家族转录因子,其表达通过诱导基质金属蛋白酶(MMP)表达而与肿瘤进展相关。本研究旨在检测E1AF mRNA表达,并确定其是否与人类胃癌的进展及MMP表达相关。我们使用半定量逆转录聚合酶链反应(RT-PCR)分析了100例胃癌组织中的E1AF mRNA表达。还分析了PEA3亚家族的另外两个成员ER81(ETV1)和ERM(ETV5)以及Ets-1和Ets-2的表达。结果与临床病理特征和MMP表达相关。还进行了免疫组织化学分析和体外侵袭试验。在100例胃癌组织中,64%检测到E1AF mRNA表达,但在相邻的非肿瘤组织中未检测到或仅微弱检测到。E1AF表达与浸润深度、淋巴管和静脉浸润、淋巴结和远处转移、病理肿瘤-淋巴结-转移分期进展及复发显著相关。E1AF阳性肿瘤患者的总生存期和无病生存期明显短于E1AF阴性肿瘤患者(分别为P < 0.0001和P < 0.0001)。在包括传统临床病理因素的多变量分析中,E1AF表达对总生存期和无病生存期仍具有显著的预测价值(分别为P = 0.0082和P = 0.0096)。在所分析的MMP中,基质溶素(MMP-7)的表达与E1AF表达显著相关。E1AF的免疫组织化学表达主要见于侵袭前沿,而基质溶素的表达常与其共定位。反义E1AF转染的MKN45胃癌细胞中基质溶素表达水平降低,体外侵袭性低于空载体转染的MKN45细胞。本研究结果提示,E1AF表达与基质溶素表达密切相关,在胃癌进展中起关键作用。